DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Hirschfield GM, Gershwin ME, Strauss R. , et al; PURIFI Study Group.
Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: a proof-of-concept study.

Hepatology 2016;
64 (01) 189-199

Download Bibliographical Data

Access:
Access: